(Q35126380)

English

Effect of off-label use of oncology drugs on pharmaceutical costs: the rituximab experience

scientific article published on May 1, 2003

In more languages

default values for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12744301

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12744301%20AND%20SRC:MED&resulttype=core&format=json

retrieved

3 November 2019

title

Effect of off-label use of oncology drugs on pharmaceutical costs: the rituximab experience (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12744301

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12744301%20AND%20SRC:MED&resulttype=core&format=json

retrieved

3 November 2019

author name string

Darren Kocs

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12744301

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12744301%20AND%20SRC:MED&resulttype=core&format=json

retrieved

3 November 2019

A. Mark Fendrick

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12744301

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12744301

retrieved

1 January 2024

language of work or name

English

1 reference

stated in

National Center for Biotechnology Information

PubMed publication ID

12744301

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12744301

retrieved

1 January 2024

publication date

1 May 2003

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12744301

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12744301%20AND%20SRC:MED&resulttype=core&format=json

retrieved

3 November 2019

published in

American Journal of Managed Care

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12744301

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12744301%20AND%20SRC:MED&resulttype=core&format=json

retrieved

3 November 2019

volume

9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12744301

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12744301%20AND%20SRC:MED&resulttype=core&format=json

retrieved

3 November 2019

issue

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12744301

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12744301%20AND%20SRC:MED&resulttype=core&format=json

retrieved

3 November 2019

page(s)

393-400; quiz 401-2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12744301

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12744301%20AND%20SRC:MED&resulttype=core&format=json

retrieved

3 November 2019

Identifiers

PubMed publication ID

12744301

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12744301

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12744301%20AND%20SRC:MED&resulttype=core&format=json

(Q35126380)

Effect of off-label use of oncology drugs on pharmaceutical costs: the rituximab experience

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)